CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

Ann: Change in substantial holding , page-4

  1. 442 Posts.
    lightbulb Created with Sketch. 7
    "There is an opportunity to invest
    at less than half the fundamental asset value for investors prepared to take on
    high risk at appropriate weightings."

    That was from the Wilson HTM report when the share price was 69 cents. Now it is 43.

    Hoping the price will settle now before April 9 when a bit more information on the issue of the diagnostic will be released to the market. ie. strategy and expected duration of the validation testing.
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.